Poly (d,l-lactic-co-glycolic) acid (PLGA) based microspheres have been extensively used as controlled drug release systems. However, the burst effect has been a persistent issue associated with such systems, especially for those prepared by the double emulsion technique. An effective approach to preventing the burst effect and achieving a more ideal drug release profile is to improve the drug distribution within the polymeric matrix. Therefore, it is of great importance to establish a rapid and robust tool for screening and optimizing the drug distribution during pre-formulation.
Introduction
In recent years microspheres fabricated with biodegradable materials, such as poly (d,l-lactic-co-glycolic) acid (PLGA), have attracted significant attention [1] [2] [3] . ! 7
Scanning Electron Microscopy (SEM)
The morphology of both the microsphere surfaces and the cross-sections were imaged by scanning electron microscopy (SEM) (Hitachi S-4800, Japan) after being coated with gold in an argon atmosphere. To section the particles, the microspheres were firstly suspended in two different embedding agents: optimal cutting temperature (OCT) compound (Shanghai solarbio Bioscience & Technology Co., LTD, China), and an aqua solution containing gelatin and glycerin prior to solidification via being stored at -20℃. The fixed samples were then frozen in liquid nitrogen for 5min and cryosectioned under -40℃based on an established method [21] .
In vitro Drug Release Measurement
Prior to the in vitro release test, 5 mL solution of nimodipine in phosphate buffered saline (PBS, pH7.4) solution (containing 0.5% w/v SDS) was placed in a dialysis bag which was submerged in 195 ml PBS solution in a constant temperature oscillator held at 37 ℃± 0.2 ℃ with 100 rpm rotation speed. The concentration of nimodipine inside or external to the dialysis bags was found to be the same after 2hr, indicating the dialysis bag itself did not affect the drug transport.
Nimodipine-loaded microspheres (30 mg) were placed in a dialysis bag, and 5 mL phosphate buffered saline (PBS, pH7.4) solution (containing 0.5% w/v SDS) added to disperse the microspheres. The dialysis bag was then submerged in PBS solution (195 mL) , and the in vitro release test was conducted in a constant temperature oscillator at 37 ℃± 0.2 ℃ and 100 rpm rotational speed. At predetermined time points, 5mL of the release medium was sampled and fresh medium added to maintain a constant total volume. The amount of drug released at each time point was quantified by UV spectrophotometry using a standard curve.
BSA-loaded spheres (50 mg) were placed in a centrifuge tube and PBS solution (1.5 mL) was added. The centrifuge tube was then put in a water bath oscillator to conduct the in vitro release test at 37 ℃± 0.2 ℃ and 100 rpm rotational speed. At each time point, the sample was centrifuged, and the supernatant was sampled to ! 8 determine the protein content using the BCA method. Fresh release medium was added in the centrifuge tube to continue the release experiment.
X-ray Diffraction (XRD)
XRD (Bruker D8 Advance, Germany) measurements were carried out at a voltage of 40 kV and a current of 40mA. Data was collected at a scan rate of 0.02°/ 0.15over a range of 5 to 50° 2θ.
Fourier Transform Infrared (FTIR) Spectroscopy
The raw materials of nimodipine and BSA, and blank and drug-loaded microspheres were mixed with potassium bromide (KBr) respectively, ground and tableted. The scan range was from 4000 to 400 cm -1 .
Modulated Temperature Differential Scanning Calorimetry (MTDSC)
MTDSC (Q1000 TA Instruments, Delaware, USA) measurements were carried out at 2 °C/min with a modulation of ±0.212°C for every 40s over a temperature range of 0 to 250 °C using standard pans. The instrument was calibrated with indium, tin and octadecane before use.
Transition Temperature Microscopy (TTM)
TTM was performed on both raw materials and microspheres using a VESTA TM system equipped with an AN-200 ThermaLever probe, both from Anasys Instruments (Santa Barbara, USA). With raw materials in loose powder, a mini tablet sample was made to ensure a flat and smooth surface for TTM measurement. To investigate the cross section of the microspheres, samples were sectioned using the same method as stated in 2.5. The voltage was calibrated to temperature by carrying out LTA measurements on three standard polymeric samples with known melting points. The experiments were carried out from room temperature at a heating rate of ! 9
Results

Measurement of particle size, drug loading and encapsulation efficiency
The drug loading and encapsulation efficiencies of the different microsphere formulations were measured and are listed in Table 1 . With both model drugs, the lowest drug loading resulted in a relatively high encapsulation efficiency while the particle size increased with an increase in drug loading. It is noted that the particle size with a general distribution of 65-100 µm did not vary significantly among different formulations, making the later analysis of drug release profiles less complicated. 
SEM results
SEM showed that the surfaces of BSA-loaded microspheres (Figure 1 a-c) were
relatively smooth compared to that of nimodipine systems (Figure 1d-f 
In vitro drug release profiles
As shown in Figure 2 , the burst release from BSA microspheres was significant with a large proportion of BSA being released during the first hour. After 40 days, there was still a considerable amount of drug that remained unreleased from the formulation. This burst release phenomenon was probably caused by the hydrophilic nature of BSA; the aqueous solubility of BSA is high, therefore when the BSA microspheres were placed in an aqueous medium for the in vitro release studies, the BSA molecules present near the surface would quickly dissolve and diffuse into the bulk release medium, which at least partially accounts for the observed burst release.
There are a number of factors that may affect the burst release, including the drug solubility, the overall drug loading and the drug level on the surface of the microspheres.
In terms of the nimodipine microspheres, the drug was released at a relatively constant rate throughout the first 40 days of the in vitro release study, indicating a well sustained release profile. After 40 days, the drug was not completely released, represented the β-sheet structure. The FTIR spectra of the BSA-loaded microspheres suggested that the majority of α-helix structure in BSA had changed to β-sheet structure after being encapsulated into microspheres. This may be due to the forming of hydrogen bonds between BSA and PLGA during encapsulation. The results of MTDSC were shown in Figures 8-10 . The thermal properties of the raw materials of BSA, nimodipine and PLGA were determined first. As shown in Figure 8 (a), BSA was characterized by two endothermic peaks at 62.5 ℃ and 215.9
℃. Previous studies [22, 23] have shown that BSA experiences two phases of change during the heating process. In the first stage, occurring at a lower temperature, the α-helix peptides may change conformation and assemble to form a random coil structure; in addition, the adjacent inverted parallel α-helix peptides may form a β-sheet structure through hydrogen bonds during the heating process. The changes at this stage are reversible. This stage involves a plurality of structural changes between many different protein structures hence the endothermic peak looks broad. In the second stage at a higher temperature, BSA degraded and the structural changes are irreversible. Based on the previous findings above, we may reasonably ascribe the first endothermic peak of BSA measured at 62.5℃ to a result of reversible changes and the second endothermic peak at 215.9 ℃ to an irreversible degradation.
As demonstrated in Figure 8 The MTDSC results of the BSA-PLGA microspheres with different drug loadings are shown in Figure 9 . The thermograms showed that with increasing drug loading the endothermic peaks associated with BSA changed accordingly. Since both BSA and PLGA had an endothermic transition around 50 ℃, and the drug loadings in the BSA microspheres were relatively low, the peaks associated with BSA at about 50 ℃ were overshadowed by the peaks associated with PLGA, hence the thermograms mainly showed the features of the PLGA. However, since the endothermic peaks near 50 ℃ were the superposition of the two components, when the amount of PLGA was almost
unchanged, the area of the peak became larger with the increase of BSA loading. The endothermic peak measured with BSA alone at 215.9℃ was not present in the thermograms of the BSA-PLGA microspheres, which was likely to be due to a combination of the low drug loading and the weak nature of such a thermal transition.
Further increase in BSA loading, however, did appear to result in a more visible endothermic peak.
The MTDSC results of the nimodipine-PLGA microspheres with different drug loadings were shown in Figure 10 . As stated earlier, pure nimodipine presented a melting point at 125.8 ℃. As for PLGA based microspheres, a 'depressed melting' was detected, indicating the compatibility/interaction (hydrogen bonding) between the two components. It was found that the higher the drug loading the greater the depressed temperature. The enthalpy of this transition also increased with drug loading; implying the nimodipine loading of microspheres had a positive correlation with the endothermic peak area. In addition, an endothermic relaxation peak was detected for all nimodipine loaded microspheres between 44-48℃, indicating a glass transition of the amorphous phase. It was notable that no marked plasticizing effect was seen which may be due to similar glass transition temperatures between PLGA and nimodipine. 
TTM results
Transition temperature microscopy (TTM) is a relatively new technique which
involves mapping a sample surface via the temperature at which a heated probe indents into that surface, thereby effectively creating a map of softening points. The
TTM color coded maps shown here correspond to an area of 50 x 50 µm for each sample. The corresponding histogram is a summary of the measured penetration temperatures. The temperature peak with the greatest intensity in the histogram corresponds to the most prevalent component/phase in the sample.
TTM was firstly used to analyze the raw materials of BSA, nimodipine and PLGA. The results were shown in Figure 11 . In the transition map of BSA, it was shown that BSA had several different thermal transitions which were expressed as different characteristic color blocks. It had previously been shown that BSA consisted of peptides of different secondary structures: 50-68 % of which are α-helix peptides, and 16-21 % β-sheet [24, 25] . Characteristic peaks appeared at multiple temperature points in the histogram of BSA, and the strongest response was concentrated in the region above 100 ℃, which could be used to analyze BSA qualitatively in the later experiment.
The thermal transition map of nimodipine consists largely of a single characteristic color. Nimodipine is a crystalline small molecule drug that has high purity when chemically synthesized and therefore it has a defined melting point.
These material characteristics account for the single color observed in the thermal transition map as well as the comparatively narrow distribution of thermal transitions in the histogram for this material. Specifically, the transitions occurred in the range of 60-90 ℃, with the highest frequency occurring at approximately 80 ℃.
The thermal transition map of the PLGA raw material was also fairly consistent.
The histogram shows that the characteristic thermal transition peaks of PLGA occur at 50-55 ℃. These findings agreed well with the value measured using DSC, i.e.
48.1℃.
After the qualitative analysis of the three substances individually, drug distribution on the surface and cross-sections of both BSA-PLGA and nimodipine-PLGA microspheres with different drug loadings were analyzed with TTM. Figure 12 showed that due to the great difference of the transition temperatures between BSA and PLGA, the distribution of BSA on the surface and internal cross-section of the
BSA-PLGA microspheres could be clearly seen. In the transition maps of the BSA-PLGA microspheres, the transitions occurring at a lower temperature, represented by blue blocks, were the areas of PLGA; while the transitions occurring at a higher temperature, represented by bright green blocks, were the areas of BSA. The transition maps of both the surfaces and the cross-sections of the microsphere formulations showed that when the BSA loading is increased from 3.66 % to 8.84 %, there was a clear increase in the characteristic colors of BSA on the transition maps.
Additionally, the quantity and intensity of the peaks on the histograms in the region above 100 ℃ (which can be attributed to BSA thermal transitions) increased with increasing BSA load. However, it must be noted that the actual drug loadings (3.66% and 8.84%) measured using chemical method were determined on the bulk samples while TTM was mapping the drug distribution on the localized surface regions of a single microsphere. Therefore, the size of the total areas of a specific color in the TTM map would not necessarily reflect on the overall drug loading.
Comparing the TTM results of the surfaces and cross-sections of the microspheres with equal drug loading, it was found that there was more area covered by the color blocks associated with BSA inside the microsphere than on the surface.
As would be expected, the quantity and intensity of the peaks associated with BSA in the histograms produced of the transition temperatures of the microsphere crosssection were all higher than those in the histograms of microsphere surface. This TTM data suggested that for BSA-PLGA microspheres of equal drug loading, more BSA was distributed on the interior of the microspheres than on the surface.
The TTM results of nimodipine microspheres are shown in Figure 13 . The results of the raw material characterization showed that the transition temperatures of PLGA and nimodipine determined by TTM were very close, which means that the characteristic color blocks of the two components were very similar. Therefore, with the nimodipine-PLGA microspheres, the transition temperature maps largely consisted of a single color block and it was very difficult to distinguish the areas corresponding to nimodipine and PLGA and also hard to monitor the distribution of nimodipine on the surface and cross-section of PLGA microspheres. It is suggested
that TTM technique is not able to monitor microstructure/drug distribution with all microsphere formulations. A critical criterion/limitation for applying this technique is that there must be a marked difference between the thermal transition temperatures of each individual components/phases in the formulation. For instance, the thermal transitions of nimodipine rich region and PLGA rich region were at similar temperatures hence overlapping characteristic color blocks in the TTM map, which complicated the differentiation. In terms of the magnitude of such difference, it is indicated in this study that it should be at least over circa 40℃ to generate distinct colors in TTM map. It was also interesting to find some round dark pink color areas in a majority of TTM maps, which could most probably be a cavity/gap region. When the probe (30nm in diameter) landed at a cavity point, there was no contact between the probe and the material and this is normally processed by the software as a low (0℃) temperature reading. This has also been seen in other investigations by our group.
Due to the limitation of using TTM color coded map discussed above, the histograms produced from the transition temperatures can be used to obtain more information about the loading of the different components. The temperature peak with the greatest intensity in the histogram corresponds to the most prevalent component/ phase in the sample. In terms of the nimodipine-PLGA microspheres in this study, at the transition temperatures near 80 ℃, where the transitions associated with nimodipine appeared, the quantity and intensity of the histogram peaks increased with increasing nimodipine load. Furthermore, when comparing the histograms of the surfaces and cross-sections of nimodipine microspheres, both the quantity and intensity of the characteristic peaks of nimodipine in the histograms of the microsphere cross-sections were higher than those in the histograms of the microsphere surface. These results indicated that when nimodipine-PLGA microspheres were prepared by the membrane-emulsification method, more nimodipine was present in the interior of the microsphere than on the surface. This relationship was more obvious in the TTM results of the nimodipine microspheres with the higher drug loading of 22.80%. At the lower nimodipine loading of 8.30%
The results of TTM, however, were strongly influenced by the properties of the sample itself:
(1) The thermal transitions of nimodipine and PLGA occurred at a similar temperature which resulted in the characterstic color blocks also being very similar; therefore, when analyzing nimodipine-PLGA microspheres, it was not possible to determine the loading or distribution of the components from the TTM maps. When melting point difference of two substances is over 40℃ TTM technology can be used to determine drug distribution.
The thermodynamic properties of BSA and PLGA were very different, however, and as a result it was possible to visually distinguish regions of BSA and PLGA on the TTM maps produced, allowing spatial distribution and BSA loading to be qualitatively assessed. It was noteworthy that, BSA showed a variety of color blocks in its own map probably because of containing the peptides with different secondary structures. However, in the thermal transition maps of the BSA microspheres, BSA was just shown by bright green color blocks, while the color blocks representing the higher temperature transitions (such as the yellow and red blocks) were not present.
This phenomenon was reflected in the histograms of BSA microspheres. In the histogram of BSA raw material, the region where the quantity and intensity of the The TTM results suggest that after being encapsulated into microspheres, the thermal transitions of BSA tended to occur at a lower temperature. The FTIR results
showed that after being encapsulated most of the α-helix peptides in BSA changed conformation to β-sheet peptides. This change in secondary structure was probably caused by the formation of hydrogen bonds with PLGA in the polymer matrix.
Moreover, with the formation of hydrogen bonds, the two components transformed to a relatively stable "dispersed system", the thermal properties of which fell in between those of BSA and PLGA separately. More specifically, the transition temperatures of BSA-PLGA individual microspheres as determined by TTM presented a lower temperature as compared to BSA alone due to the contribution of the thermal properties of PLGA. Furthermore, it was also found that BSA within the PLGA matrix showed a significantly slower release rate although it has a high solubility. This was due to the hydrophilic nature of the drug as well as the hydrogen bonding formed between the drug and matrix in the dispersed system.
One can conclude from the findings above that TTM is a very promising technique for monitoring the microstructure of individual microspheres provided that all components in the formulation present a considerable difference in their thermal properties.
(2) The drug loading achieved in the nimodipine-PLGA microspheres was significantly higher than that achieved in the BSA-PLGA microspheres; however, in the histograms the thermal transition peaks associated with nimodipine were much lower than the peaks associated with BSA. Also, in the TTM maps of BSA microspheres, the area that was associated with BSA transitions was very large even though the drug loading was low. The differences in the structure and properties ! 32 between nimodipine and BSA as well as their compatibility with PLGA as detailed below may explain this phenomenon.
Nimodipine is a small molecule drug, with a molecular weight of 418 and a simple spatial structure while PLGA is a long chain polymer. Due to the lipophilic nature of both materials, they present very good compatibility. The SEM images showed very few cavities in the cross-section of the nimodipine-PLGA microspheres, demonstrating a rather solid structure with such a formulation. The relatively high compatibility between nimodipine and PLGA as well as the stabilizing effect of PLGA on the relatively small molecules resulted in a well dispersed system, as reflected by XRD and MTDSC.
The molecular weight of the BSA (approximately 68 KDa) is much larger than nimodipine, and as a protein molecule, BSA has a spatial configuration with very complex secondary and tertiary conformations. These properties indicate that the same mass of BSA would occupy much larger space as compared to nimodipine. Its hydrophilic nature also makes it less compatible with PLGA. As a consequence, the SEM images showed many cavities inside the BSA microspheres due to the microspheres being prepared by double emulsion-solvent evaporation technique. The combination of MTDSC and XRD results demonstrated a fully amorphous structure with two separated phases for BSA-PLGA microspheres. This was most likely due to the incompatibility between BSA which is hydrophilic and water-soluble, and PLGA which is lipophilic and soluble in organic solvent. Therefore, once BSA was encapsulated within the microspheres it could only stay in the cavities of the PLGA matrix formed as a result of the double-emulsion production method, retaining its original independent phase. As a result, although the drug loading of BSA microspheres was low, the BSA distribution area shown in the TTM maps was relatively large as the system was phase-separated. To conclude, the differences in the chemical nature and solubilities of the components, and therefore the preparation method required for a formulation, would significantly affect the microstructure measured by TTM. would quickly dissolve and diffuse into the bulk aqueous release medium resulting in the burst release effect observed. However, the TTM maps also showed that the BSA present on the surface of the microspheres was just a small part of the total drug content as the TTM maps of the microsphere cross-sections showed that more BSA appeared to be present inside the microspheres. Therefore, despite the significant burst release, the majority of the BSA was distributed inside the microspheres and was not so easily released. The TTM results and in vitro release studies supported each other well for the BSA-PLGA microsphere formulations.
Due to the good chemical compatibility between nimodipine and PLGA, nimodipine could be distributed uniformly in the amorphous state throughout the PLGA matrix in the nimodipine-PLGA microspheres. The TTM results supported this proposed distribution, and the in vitro release studies show that nimodipine was released with a relatively constant rate as the PLGA matrix degraded. Therefore, the TTM results and in vitro release studies were again in agreement, and the TTM maps were able to help better understand the drug release profiles from the microsphere formulations.
Conclusions
In conclusion, TTM is a novel thermal and imaging technique that can be applied to study the spatial drug distribution of as single microspheres in relation to their in vitro drug release performance, especially for formulations consisting of components with significantly different thermal properties. By using TTM in combination with other techniques such as XRD, FTIR and MTDSC, the physical and chemical ! 34
properties of microspheres could be understood more comprehensively as the different techniques complement each other.
